J. Heneghan and R. Charlton, Wait time deconstructed, Human Immunology, vol.76, p.47, 2015.

D. S. Keith and G. M. Vranic, Approach to the Highly Sensitized Kidney Transplant Candidate, Clinical Journal of the American Society of Nephrology, vol.11, issue.4, pp.684-693, 2016.

L. R. Gayo, M. O. Lopez-oliva, L. O. Alvarez, E. Gonzalez, R. Selgas et al., Acute Rejection and Short-Term Outcomes in Highly Sensitized Kidney Transplant Recipients, Transplantation, vol.102, p.S480, 2018.

C. Lefaucheur, A. Loupy, G. S. Hill, J. Andrade, D. Nochy et al., Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation, Journal of the American Society of Nephrology, vol.21, issue.8, pp.1398-1406, 2010.

M. Ziemann, W. Altermann, K. Angert, W. Arns, A. Bachmann et al., Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation, Clinical Journal of the American Society of Nephrology, vol.14, issue.7, pp.1056-1066, 2019.

I. Pérez-flores, J. L. Santiago, N. Calvo-romero, A. Barrientos-guzmán, and A. I. Sánchez-fructuoso, Different Impact of Pretransplant Anti-HLA Antibodies Detected by Luminex in Highly Sensitized Renal Transplanted Patients, BioMed Research International, vol.2013, pp.1-5, 2013.

I. Pérez-flores, J. L. Santiago, N. Calvo-romero, A. Barrientos-guzmán, and A. I. Sánchez-fructuoso, Different Impact of Pretransplant Anti-HLA Antibodies Detected by Luminex in Highly Sensitized Renal Transplanted Patients, BioMed Research International, vol.2013, pp.1-5, 2013.

G. Einecke, B. Sis, J. Reeve, M. Mengel, P. M. Campbell et al., Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure, American Journal of Transplantation, vol.9, issue.11, pp.2520-2531, 2009.

F. H. Claas, M. D. Witvliet, R. J. Duquesnoy, G. G. Persijn, and I. I. Doxiadis, The Acceptable Mismatch Program as a Fast Tool for Highly Sensitized Patients Awaiting a Cadaveric Kidney Transplantation: Short Waiting Time and Excellent Graft Outcome, Transplantation Journal, vol.78, issue.2, pp.190-193, 2004.

A. M. Jackson, The Virtual Crossmatch: An Essential Tool for Transplanting Sensitized Patients, Clin Transpl, pp.131-137, 2014.

C. A. Van-kampen, M. F. Versteeg-vd-voort-maarschalk, J. Langerak-langerak, D. L. Roelen, and F. H. Claas, Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child, Human Immunology, vol.63, issue.6, pp.452-458, 2002.

M. F. Murphy, P. Metcalfe, J. Ord, T. A. Lister, and A. H. Waters, Disappearance of HLA and platelet-specific antibodies in acute leukaemia patients alloimmunized by multiple transfusions, British Journal of Haematology, vol.67, issue.3, pp.255-260, 1987.

M. Togninalli, D. Yoneoka, A. G. Kolios, K. Borgwardt, and J. Nilsson, Pretransplant Kinetics of Anti-HLA Antibodies in Patients on the Waiting List for Kidney Transplantation, Journal of the American Society of Nephrology, vol.30, issue.11, pp.2262-2274, 2019.

L. Marino, J. Alberú, and L. E. Morales-buenrostro, Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Renal Failure and in Kidney Transplant Recipients, Clin Transpl, vol.32, pp.161-71, 2016.

J. E. Locke, A. A. Zachary, D. S. Warren, D. L. Segev, J. A. Houp et al., Proinflammatory Events Are Associated with Significant Increases in Breadth and Strength of HLA-Specific Antibody, American Journal of Transplantation, vol.9, issue.9, pp.2136-2139, 2009.

A. R. Tambur, P. Campbell, A. S. Chong, S. Feng, M. L. Ford et al., Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report, American Journal of Transplantation, vol.20, issue.10, pp.2652-2668, 2020.

M. Schnaidt, C. Weinstock, M. Jurisic, B. Schmid-horch, A. Ender et al., HLA Antibody Specification Using Single-Antigen Beads?A Technical Solution for the Prozone Effect, Transplantation, vol.92, issue.5, pp.510-515, 2011.

G. Guidicelli, J. Visentin, N. Franchini, C. Borg, P. Merville et al., Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays, HLA, vol.91, issue.6, pp.507-513, 2018.

J. Visentin, M. Vigata, S. Daburon, C. Contin-bordes, V. Fremeaux-bacchi et al., Deciphering Complement Interference in Anti?Human Leukocyte Antigen Antibody Detection With Flow Beads Assays, Transplantation, vol.98, issue.6, pp.625-631, 2014.

J. Visentin, M. Vigata, S. Daburon, C. Contin-bordes, V. Fremeaux-bacchi et al., Deciphering Complement Interference in Anti?Human Leukocyte Antigen Antibody Detection With Flow Beads Assays, Transplantation, vol.98, issue.6, pp.625-631, 2014.

J. Visentin, T. Bachelet, C. Borg, N. Franchini, T. Nong et al., Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay, Transplantation, vol.101, issue.3, pp.624-630, 2017.

M. Maiers, L. Gragert, and W. Klitz, High-resolution HLA alleles and haplotypes in the United States population, Human Immunology, vol.68, issue.9, pp.779-788, 2007.

. Lindemann, . Oesterreich, . Wilde, . Eisenberger, . Muelling et al., Sex-Specific Differences in HLA Antibodies after Pneumococcal Vaccination in Kidney Transplant Recipients, Vaccines, vol.7, issue.3, p.84, 2019.

I. Katerinis, K. Hadaya, R. Duquesnoy, S. Ferrari-lacraz, S. Meier et al., De Novo Anti-HLA Antibody After Pandemic H1N1 and Seasonal Influenza Immunization in Kidney Transplant Recipients, American Journal of Transplantation, vol.11, issue.8, pp.1727-1733, 2011.

J. Alberú, L. E. Morales-buenrostro, C. De-leo, M. I. Vargas-rojas, L. A. Marino-vázquez et al., A non-allogeneic stimulus triggers the production of de novo HLA antibodies in healthy adults, Transplant Immunology, vol.18, issue.2, pp.166-171, 2007.

L. D?orsogna, H. Van-den-heuvel, C. Van-kooten, S. Heidt, and F. H. Claas, Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms, Immunogenetics, vol.69, issue.8-9, pp.631-641, 2017.

N. Lachmann, C. Schönemann, N. El-awar, M. Everly, K. Budde et al., Dynamics and epitope specificity of anti-human leukocyte antibodies following renal allograft nephrectomy, Nephrology Dialysis Transplantation, vol.31, issue.8, pp.1351-1359, 2016.

D. Bello, A. , C. , N. Sallusto, F. Guilbeau-frugier et al., Donor-Specific Antibodies after Ceasing Immunosuppressive Therapy, with or without an Allograft Nephrectomy, CJASN. août, vol.7, issue.8, pp.1310-1319, 2012.

T. Bachelet, L. Couzi, S. Lepreux, M. Legeret, G. Pariscoat et al., Kidney Intragraft Donor-Specific Antibodies as Determinant of Antibody-Mediated Lesions and Poor Graft Outcome, American Journal of Transplantation, vol.13, issue.11, pp.2855-2864, 2013.

D. Milongo, N. Kamar, A. Del-bello, C. Guilbeau-frugier, F. Sallusto et al., Allelic and Epitopic Characterization of Intra-Kidney Allograft Anti-HLA Antibodies at Allograft Nephrectomy, American Journal of Transplantation, vol.17, issue.2, pp.420-431, 2016.

A. S. Chong and M. Alegre, The impact of infection and tissue damage in solid-organ transplantation, Nature Reviews Immunology, vol.12, issue.6, pp.459-471, 2012.

J. Dausset, Iso-leuco-anticorps, Acta Haematologica, vol.20, issue.1-4, pp.156-166, 1958.

J. J. Van-rood, J. G. Eernisse, and A. Van-leeuwen, Leucocyte Antibodies in Sera from Pregnant Women, Nature, vol.181, issue.4625, pp.1735-1736, 1958.

P. I. Terasaki and J. D. Mcclelland, Microdroplet Assay of Human Serum Cytotoxins, Nature, vol.204, issue.4962, pp.998-1000, 1964.

B. Bain, M. R. Vas, and L. Lowenstein, The Development of Large Immature Mononuclear Cells in Mixed Leukocyte Cultures, Blood, vol.23, issue.1, pp.108-116, 1964.

D. B. Amos, H. F. Seigler, J. G. Southworth, and F. E. Ward, Skin graft rejection between subjects genotyped for HL-A, Transplant Proc. mars, vol.1, issue.1, pp.342-348, 1969.

P. I. Terasaki, D. L. Vredevoe, K. A. Porter, M. R. Mickey, T. L. Marchioro et al., SEROTYPING FOR HOMOTRANSPLANTATION V. EVALUATION OF A MATCHING SCHEME, Transplantation, vol.4, issue.6, pp.688-699, 1966.

J. Klein and . George, Snell's first foray into the unexplored territory of the major histocompatibility complex, Genetics, vol.159, issue.2, pp.435-444, 2001.

, The International HapMap Project, Nature, vol.426, issue.6968, pp.789-796, 2003.

R. Horton, L. Wilming, V. Rand, R. C. Lovering, E. A. Bruford et al., Gene map of the extended human MHC, Nature Reviews Genetics, vol.5, issue.12, pp.889-899, 2004.

A. Raval, N. Puri, P. C. Rath, and R. K. Saxena, Cytokine regulation of expression of class I MHC antigens, Experimental & Molecular Medicine, vol.30, issue.1, pp.1-13, 1998.

D. Meyer, V. R. C.-aguiar, B. D. Bitarello, D. Y. C.-brandt, and K. Y. Nunes, A genomic perspective on HLA evolution, Immunogenetics, vol.70, issue.1, pp.5-27, 2017.

C. Van-oosterhout, A new theory of MHC evolution: beyond selection on the immune genes, Proceedings of the Royal Society B: Biological Sciences, vol.276, issue.1657, pp.657-665, 2008.

A. Sorokowska, D. Pietrowski, L. Schäfer, J. Kromer, A. H. Schmidt et al., Human Leukocyte Antigen similarity decreases partners' and strangers' body odor attractiveness for women not using hormonal contraception, Hormones and Behavior. nov, vol.106, pp.144-153, 2018.

E. Riley and O. Olerup, HLA polymorphisms and evolution, Immunology Today. sept, vol.13, issue.9, pp.333-338, 1992.

T. M. Conlon, K. Saeb-parsy, J. L. Cole, R. Motallebzadeh, M. S. Qureshi et al., Germinal Center Alloantibody Responses Are Mediated Exclusively by Indirect-Pathway CD4 T Follicular Helper Cells, The Journal of Immunology, vol.188, issue.6, pp.2643-2652, 2012.

A. A. Fuller, J. E. Trevithick, G. E. Rodey, P. Parham, and T. C. Fuller, Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes, Human Immunology. juill, vol.28, issue.3, pp.284-305, 1990.

B. D. Schwartz, L. K. Luehrman, T. Lee, and G. E. Rodey, HLA serological cross-reactivity: HLA-B15 has two public antigens, Human Immunology, vol.1, issue.4, pp.331-345, 1980.

T. Wujciak and G. Opelz, EVALUATION OF HLA MATCHING FOR CREG ANTIGENS IN EUROPE1, Transplantation, vol.68, issue.8, pp.1097-1099, 1999.

N. El-awar, V. Jucaud, and A. Nguyen, HLA Epitopes: The Targets of Monoclonal and Alloantibodies Defined, Journal of Immunology Research, vol.2017, pp.1-16, 2017.

R. J. Duquesnoy, HLA epitope based matching for transplantation, Transplant Immunology, vol.31, issue.1, pp.1-6, 2014.

R. J. Duquesnoy, S. Takemoto, P. De-lange, I. I. Doxiadis, G. M. Schreuder et al., HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival1, Transplantation, vol.75, issue.6, pp.884-889, 2003.

F. H. Claas, M. D. Witvliet, R. J. Duquesnoy, G. G. Persijn, and I. I. Doxiadis, The Acceptable Mismatch Program as a Fast Tool for Highly Sensitized Patients Awaiting a Cadaveric Kidney Transplantation: Short Waiting Time and Excellent Graft Outcome, Transplantation Journal, vol.78, issue.2, pp.190-193, 2004.

R. J. Duquesnoy and M. Marrari, Correlations between Terasaki?s HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens, Tissue Antigens, vol.74, issue.2, pp.117-133, 2009.

A. R. Tambur and F. H. Claas, HLA Epitopes as Viewed by Antibodies: What Is it All About?, American Journal of Transplantation, vol.15, issue.5, pp.1148-1154, 2015.

M. R. Clatworthy, M. Espeli, N. Torpey, and K. Smith, The generation and maintenance of serum alloantibody, Current Opinion in Immunology, vol.22, issue.5, pp.669-681, 2010.

D. Kerjaschki, Lymphatic Neoangiogenesis in Human Kidney Transplants Is Associated with Immunologically Active Lymphocytic Infiltrates, Journal of the American Society of Nephrology, vol.15, issue.3, pp.603-612, 2004.

J. R. Wehner, K. Fox-talbot, M. K. Halushka, C. Ellis, A. A. Zachary et al., B Cells and Plasma Cells in Coronaries of Chronically Rejected Cardiac Transplants: Transplantation. mai, vol.89, pp.1141-1149, 2010.

A. Hammer, H. Hutter, and G. Dohr, HLA Class I Expression on the Materno-Fetal Interface, American Journal of Reproductive Immunology, vol.38, issue.3, pp.150-157, 1997.

M. Singh, J. Rajak, S. Kadam, and S. B.-rajadhyaksha, Alloimmunization and Role of HLA in Pregnancy, Complications of Pregnancy, 2019.

. Intechopen, , 2019.

C. Gurbuz, B. Soyoz, M. , O. Okyay, D. et al., Comparison of Anti-HLA Antibody Production According to Gestational Periods in Pregnant Women, Transplantation Proceedings. avr, vol.49, issue.3, pp.464-470, 2017.

D. J. Triulzi, S. Kleinman, R. M. Kakaiya, M. P. Busch, P. J. Norris et al., The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy, Transfusion, vol.49, issue.9, pp.1825-1835, 2009.

L. Küssel, H. Herkner, M. Wahrmann, F. Eskandary, K. Doberer et al., Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes, Scientific Reports, vol.7, issue.1, p.13524, 2017.

J. Lee, R. Romero, Y. Xu, J. Miranda, W. Yoo et al., Detection of Anti-HLA Antibodies in Maternal Blood in the Second Trimester to Identify Patients at Risk of Antibody-Mediated Maternal Anti-Fetal Rejection and Spontaneous Preterm Delivery, American Journal of Reproductive Immunology, vol.70, issue.2, pp.162-175, 2013.

G. S. Balasubramaniam, M. Morris, A. Gupta, I. R. Mesa, R. Thuraisingham et al., Allosensitization Rate of Male Patients Awaiting First Kidney Grafts After Leuko-Depleted Blood Transfusion, Transplantation, vol.93, issue.4, pp.418-422, 2012.

J. Hyun, K. D. Park, Y. Yoo, B. Lee, B. Y. Han et al., Effects of Different Sensitization Events on HLA Alloimmunization in Solid Organ Transplantation Patients, Transplantation Proceedings, vol.44, issue.1, pp.222-225, 2012.

K. J. Kao, D. J. Cook, and J. C. Scornik, Quantitative analysis of platelet surface HLA by W6/32 anti-HLA monoclonal antibody, Blood, vol.68, issue.3, pp.627-632, 1986.

E. T. Everett, K. Kao, and J. C. Scornik, CLASS I HLA MOLECULES ON HUMAN ERYTHROCYTES QUANTITATION AND TRANSFUSION EFFECTS, Transplantation, vol.44, issue.1, pp.123-128, 1987.

J. C. Scornik, W. W. Pfaff, R. J. Howard, and S. J. Metz, Blood transfusions as an in vivo test for alloimmune responsiveness, Human Immunology, vol.40, issue.12, p.131, 1994.

E. G. Reisner, D. D. Kostyu, G. Phillips, C. Walker, and D. V. Dawson, Alloantibody responses in multiply transfused sickle cell patients, Tissue Antigens, vol.30, issue.4, pp.161-166, 2008.

M. Bajpai, B. Kaura, N. Marwaha, S. Kumari, R. R. Sharma et al., Platelet alloimmunization in multitransfused patients with haemato-oncological disorders, Natl Med J India. juin, vol.18, issue.3, pp.134-140, 2005.

C. Wiebe, I. W. Gibson, T. D. Blydt-hansen, D. Pochinco, P. E. Birk et al., Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients WithDe NovoDonor-Specific Antibody, American Journal of Transplantation, vol.15, issue.11, pp.2921-2930, 2015.

J. K. Berga, L. Mateu, S. B. Catalan, N. P. Alcaraz, A. S. Calabuig et al., Donor-Specific HLA Antibodies: Risk Factors and Outcomes After Kidney Transplantation, Transplantation Proceedings. juill, vol.43, issue.6, pp.2154-2160, 2011.

J. G. O?leary, M. Samaniego, M. Crespo-barrio, L. Potena, A. Zeevi et al., The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients, Transplantation, vol.100, issue.1, pp.39-53, 2016.

M. Willicombe, P. Brookes, R. Sergeant, E. Santos-nunez, C. Steggar et al., De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy, Transplantation Journal, vol.94, issue.2, pp.172-177, 2012.

S. J. Fidler, A. B. Irish, W. Lim, P. Ferrari, C. S. Witt et al., Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death, Transplant Immunology, vol.28, issue.4, pp.148-153, 2013.

D. Sawinski, K. A. Forde, J. Trofe-clark, P. Patel, B. Olivera et al., Persistent BK Viremia Does Not Increase Intermediate-Term Graft Loss but Is Associated with De Novo Donor-Specific Antibodies, Journal of the American Society of Nephrology, vol.26, issue.4, pp.966-975, 2014.

D. Bello, A. Congy, N. Sallusto, F. Cardeau-desangles, I. Fort et al., Human Leukocyte Antigen Immunization After Early Allograft Nephrectomy: Transplantation Journal. mai, vol.93, issue.9, pp.936-977, 2012.

D. Bello, A. , C. , N. Sallusto, F. Guilbeau-frugier et al., Donor-Specific Antibodies after Ceasing Immunosuppressive Therapy, with or without an Allograft Nephrectomy, CJASN. août, vol.7, issue.8, pp.1310-1319, 2012.

M. Marrari and R. J. Duquesnoy, Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant, Transplant Immunology. févr, vol.22, issue.3-4, pp.105-114, 2010.

J. C. Scornik and H. Kriesche, Human leukocyte antigen sensitization after transplant loss: timing of antibody detection and implications for prevention, Human Immunology. mai, vol.72, issue.5, pp.398-401, 2011.

H. Meier-kriesche, J. C. Scornik, B. Susskind, S. Rehman, and J. D. Schold, A Lifetime Versus a Graft Life Approach Redefines the Importance of HLA Matching in Kidney Transplant Patients, Transplantation, vol.88, issue.1, pp.23-29, 2009.

T. C. Fuller, A. Fuller, . The, . Hla-class-i-allodeterminant, . With et al., Transplantation. juill, vol.68, issue.2, pp.173-82, 1999.

J. Gralla, S. Tong, and A. C. Wiseman, The Impact of Human Leukocyte Antigen Mismatching on Sensitization Rates and Subsequent Retransplantation After First Graft Failure in Pediatric Renal Transplant Recipients, Transplantation Journal, vol.95, issue.10, pp.1218-1224, 2013.

L. E. Morales-buenrostro, P. I. Terasaki, L. A. Marino-vázquez, J. Lee, N. El-awar et al., Natural" Human Leukocyte Antigen Antibodies Found in Nonalloimmunized Healthy Males: Transplantation, vol.86, pp.1111-1116, 2008.

H. A. El-aggan, F. Sidkey, D. A. El-gezery, and E. Ghoneim, Circulating anti-HLA antibodies in patients with chronic hepatitis C: relation to disease activity, Egypt J Immunol, vol.11, issue.2, pp.71-80, 2004.

S. Heidt, M. C. Feltkamp, G. E. Karahan, C. S. De-brouwer, J. Langerak-langerak et al., No Evidence for Cross-reactivity of Virus-specific Antibodies With HLA Alloantigens: Transplantation, vol.102, pp.1844-1853, 2018.

A. A. Hirata and P. I. Terasaki, Cross-Reactions between Streptococcal M Proteins and Human Transplantation Antigens, Science. 29 mai, vol.168, issue.3935, pp.1095-1101, 1970.

A. A. Hirata, F. C. Mcintire, P. I. Terasaki, and K. K. Mittal, CROSS REACTIONS BETWEEN HUMAN TRANSPLANTATION ANTIGENS AND BACTERIAL LIPOPOLYSACCHARIDES1, Transplantation, vol.15, issue.5, pp.441-445, 1973.

M. H. Ravindranath, H. Kaneku, N. El-awar, L. E. Morales-buenrostro, and P. I. Terasaki, Antibodies to HLA-E in Nonalloimmunized Males: Pattern of HLA-Ia Reactivity of Anti-HLA-E-Positive Sera, JI. 1 août, vol.185, issue.3, pp.1935-1983, 2010.

J. Visentin, G. Guidicelli, T. Bachelet, C. Jacquelinet, B. Audry et al., Denatured Class I Human Leukocyte Antigen Antibodies in Sensitized Kidney Recipients, Transplantation, vol.98, issue.7, pp.738-744, 2014.

M. Schnaidt, C. Weinstock, M. Jurisic, B. Schmid-horch, A. Ender et al., HLA Antibody Specification Using Single-Antigen Beads?A Technical Solution for the Prozone Effect, Transplantation, vol.92, issue.5, pp.510-515, 2011.

G. Guidicelli, J. Visentin, N. Franchini, C. Borg, P. Merville et al., Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays, HLA, vol.91, issue.6, pp.507-513, 2018.

H. G. Otten, M. C. Verhaar, H. P. Borst, M. Van-eck, W. G. Van-ginkel et al., The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation, Clinical & Experimental Immunology, vol.173, issue.3, pp.536-543, 2013.

E. J. Griffiths, R. E. Nelson, P. J. Dupont, and A. N. Warrens, SKEWING OF PRETRANSPLANT ANTI-HLA CLASS I ANTIBODIES OF IMMUNOGLOBULIN G ISOTYPE SOLELY TOWARD IMMUNOGLOBULIN G1 SUBCLASS IS ASSOCIATED WITH POORER RENAL ALLOGRAFT SURVIVAL, Transplantation, vol.77, issue.11, pp.1771-1773, 2004.

F. Kushihata, J. Watanabe, A. Mulder, F. Claas, and J. C. Scornik, Human Leukocyte Antigen Antibodies and Human Complement Activation: Role of IgG Subclass, Specificity, and Cytotoxic Potential, Transplantation, vol.78, issue.7, pp.995-1001, 2004.

C. Lefaucheur, D. Viglietti, C. Bentlejewski, J. Duong-van-huyen, D. Vernerey et al., IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury, Journal of the American Society of Nephrology, vol.27, issue.1, pp.293-304, 2015.

D. Lowe, R. Higgins, D. Zehnder, and D. C. Briggs, Significant IgG subclass heterogeneity in HLA-specific antibodies: Implications for pathogenicity, prognosis, and the rejection response, Human Immunology, vol.74, issue.5, pp.666-672, 2013.

A. Babu, A. Andreou, D. Briggs, N. Krishnan, R. Higgins et al., Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study, Clin Transpl, vol.32, pp.173-182, 2016.

M. Arnold, C. Bach, F. M. Heinemann, P. A. Horn, M. Ziemann et al., Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival, International Journal of Immunogenetics, vol.45, issue.3, pp.95-101, 2018.

S. Calp-inal, M. Ajaimy, M. L. Melamed, C. Savchik, P. Masiakos et al., The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation, Kidney International, vol.89, issue.1, pp.209-216, 2016.

A. Zeevi, J. Lunz, B. Feingold, M. Shullo, C. Bermudez et al., Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients, The Journal of Heart and Lung Transplantation, vol.32, issue.1, pp.98-105, 2013.

G. Bartel, K. Brown, R. Phillips, Q. Peng, W. Zhou et al., Donor specific transplant tolerance is dependent on complement receptors, Transplant International, vol.26, issue.1, pp.99-108, 2012.

G. Guidicelli, F. Guerville, S. Lepreux, C. Wiebe, O. Thaunat et al., Non-Complement?Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival, Journal of the American Society of Nephrology, vol.27, issue.2, pp.615-625, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01953712

M. Yell, B. L. Muth, D. B. Kaufman, A. Djamali, and T. M. Ellis, C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection, Transplantation, vol.99, issue.6, pp.1151-1155, 2015.

A. M. Jackson, The Virtual Crossmatch: An Essential Tool for Transplanting Sensitized Patients, Clin Transpl, pp.131-137, 2014.

F. Li, J. Wei, N. M. Valenzuela, C. Lai, Q. Zhang et al., Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts, The Journal of Heart and Lung Transplantation, vol.34, issue.4, pp.580-587, 2015.

M. E. Ziegler, Y. Jin, S. H. Young, E. Rozengurt, and E. F. Reed, HLA class I-mediated stress fiber formation requires ERK1/2 activation in the absence of an increase in intracellular Ca2+in human aortic endothelial cells, American Journal of Physiology-Cell Physiology, vol.303, issue.8, pp.C872-C882, 2012.

Y. Jin, N. M. Valenzuela, X. Zhang, E. Rozengurt, and E. F. Reed, HLA Class II?Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection, The Journal of Immunology, vol.200, issue.7, pp.2372-2390, 2018.

F. M. Naemi, V. Carter, J. A. Kirby, and S. Ali, Anti-Donor HLA Class I Antibodies, Transplantation Journal, vol.96, issue.3, pp.258-266, 2013.

K. Narayanan, A. Jaramillo, D. L. Phelan, and T. Mohanakumar, Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway, European Journal of Immunology, vol.34, issue.8, pp.2303-2312, 2004.

M. Yamakuchi, N. C. Kirkiles-smith, M. Ferlito, S. J. Cameron, C. Bao et al., Antibody to human leukocyte antigen triggers endothelial exocytosis, Proceedings of the National Academy of Sciences, vol.104, issue.4, pp.1301-1306, 2007.

E. A. Albrecht, A. M. Chinnaiyan, S. Varambally, C. Kumar-sinha, T. R. Barrette et al., C5a-Induced Gene Expression in Human Umbilical Vein Endothelial Cells, The American Journal of Pathology, vol.164, issue.3, pp.849-859, 2004.

M. M. Markiewski, B. Nilsson, K. Nilsson-ekdahl, T. E. Mollnes, and J. D. Lambris, Complement and coagulation: strangers or partners in crime?, Trends in Immunology, vol.28, issue.4, pp.184-192, 2007.

J. T. Bay, L. Schejbel, H. O. Madsen, S. S. Sørensen, J. M. Hansen et al., Low C4 gene copy numbers are associated with superior graft survival in patients transplanted with a deceased donor kidney, Kidney International, vol.84, issue.3, pp.562-569, 2013.

N. Kojc and ?. Ve?eri?-haler, Antibody Mediated Rejection in Kidney Transplant Recipients, Perioperative Care for Organ Transplant Recipient, 2019.

S. Yazdani, J. Callemeyn, S. Gazut, E. Lerut, H. De-loor et al., Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation, Kidney International, vol.95, issue.1, pp.188-198, 2019.
URL : https://hal.archives-ouvertes.fr/hal-01964955

C. Rosales, Fc? Receptor Heterogeneity in Leukocyte Functional Responses. Front Immunol, vol.20

C. Lefaucheur, A. Loupy, G. S. Hill, J. Andrade, D. Nochy et al., Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation, Journal of the American Society of Nephrology, vol.21, issue.8, pp.1398-1406, 2010.

O. O. Adebiyi, J. Gralla, P. Klem, B. Freed, S. Davis et al., Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients, American Journal of Transplantation, vol.16, issue.12, pp.3458-3467, 2016.

M. Ziemann, W. Altermann, K. Angert, W. Arns, A. Bachmann et al., Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation, Clinical Journal of the American Society of Nephrology, vol.14, issue.7, pp.1056-1066, 2019.

E. Bailly, D. Anglicheau, G. Blancho, P. Gatault, V. Vuiblet et al., Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation, Transplantation, vol.102, issue.4, pp.688-698, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01838460

S. C. Jordan, T. Lorant, J. Choi, C. Kjellman, L. Winstedt et al., IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation, New England Journal of Medicine, vol.377, issue.5, pp.442-453, 2017.

L. D. Cornell, C. A. Schinstock, M. J. Gandhi, W. K. Kremers, and M. D. Stegall, Positive Crossmatch Kidney Transplant Recipients Treated With Eculizumab: Outcomes Beyond 1 Year, American Journal of Transplantation, vol.15, issue.5, pp.1293-1302, 2015.

M. J. Everly, P. I. Terasaki, and H. L. Trivedi, Durability of Antibody Removal Following Proteasome Inhibitor-Based Therapy, Transplantation, vol.93, issue.6, pp.572-577, 2012.

A. A. Vo, A. Zeevi, J. Choi, K. Cisneros, M. Toyoda et al., A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients, Transplantation, vol.99, issue.2, pp.299-308, 2015.

J. Choi, O. Aubert, A. O. Vo, A. Loupy, M. Haas et al., Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients, American Journal of Transplantation, vol.17, issue.9, pp.2381-2389, 2017.

E. Pouliquen, A. Koenig, C. C. Chen, A. Sicard, M. Rabeyrin et al., Recent advances in renal transplantation: antibody-mediated rejection takes center stage, F1000Prime Reports, vol.7, p.51, 2015.

S. S. Wan, T. D. Ying, K. Wyburn, D. M. Roberts, M. Wyld et al., The Treatment of Antibody-Mediated Rejection in Kidney Transplantation, Transplantation, vol.102, issue.4, pp.557-568, 2018.

M. Maruyama, K. Lam, and K. Rajewsky, Memory B-cell persistence is independent of persisting immunizing antigen, Nature, vol.407, issue.6804, pp.636-642, 2000.

M. Lúcia, S. Luque, E. Crespo, E. Melilli, J. M. Cruzado et al., Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation, Kidney International, vol.88, issue.4, pp.874-887, 2015.

R. Snanoudj, F. H. Claas, S. Heidt, C. Legendre, L. Chatenoud et al., Restricted specificity of peripheral alloreactive memory B cells in HLA-sensitized patients awaiting a kidney transplant, Kidney International, vol.87, issue.6, pp.1230-1240, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02376379

J. Alberú, L. E. Morales-buenrostro, C. De-leo, M. I. Vargas-rojas, L. A. Marino-vázquez et al., A non-allogeneic stimulus triggers the production of de novo HLA antibodies in healthy adults, Transplant Immunology, vol.18, issue.2, pp.166-171, 2007.

I. Katerinis, K. Hadaya, R. Duquesnoy, S. Ferrari-lacraz, S. Meier et al., De Novo Anti-HLA Antibody After Pandemic H1N1 and Seasonal Influenza Immunization in Kidney Transplant Recipients, American Journal of Transplantation, vol.11, issue.8, pp.1727-1733, 2011.

. Lindemann, . Oesterreich, . Wilde, . Eisenberger, . Muelling et al., Sex-Specific Differences in HLA Antibodies after Pneumococcal Vaccination in Kidney Transplant Recipients, Vaccines, vol.7, issue.3, p.84, 2019.

L. Marino, J. Alberú, and L. E. Morales-buenrostro, Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Renal Failure and in Kidney Transplant Recipients, Clin Transpl, vol.32, pp.161-71, 2016.

A. S. Chong and M. Alegre, The impact of infection and tissue damage in solid-organ transplantation, Nature Reviews Immunology, vol.12, issue.6, pp.459-471, 2012.

J. E. Locke, A. A. Zachary, D. S. Warren, D. L. Segev, J. A. Houp et al., Proinflammatory Events Are Associated with Significant Increases in Breadth and Strength of HLA-Specific Antibody, American Journal of Transplantation, vol.9, issue.9, pp.2136-2139, 2009.

S. Candon, E. Thervet, P. Lebon, C. Suberbielle, J. Zuber et al., Humoral and Cellular Immune Responses after Influenza Vaccination in Kidney Transplant Recipients, American Journal of Transplantation, vol.9, issue.10, pp.2346-2354, 2009.

T. Fairhead, E. Hendren, K. Tinckam, C. Rose, C. H. Sherlock et al., Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients, Transplant Infectious Disease, vol.14, issue.6, pp.575-583, 2012.

W. R. Mulley, C. Dendle, J. E. Ling, and S. R. Knight, Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis, The Journal of Heart and Lung Transplantation, vol.37, issue.7, pp.844-852, 2018.

L. D?orsogna, H. Van-den-heuvel, C. Van-kooten, S. Heidt, and F. H. Claas, Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms, Immunogenetics, vol.69, issue.8-9, pp.631-641, 2017.

D. W. Bianchi, G. K. Zickwolf, G. J. Weil, S. Sylvester, and M. A. Demaria, Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum., Proceedings of the National Academy of Sciences, vol.93, issue.2, pp.705-708, 1996.

J. J. Friedewald and N. Turgeon, Early Experience with the New Kidney Allocation System, Clinical Journal of the American Society of Nephrology, vol.12, issue.12, pp.2060-2062, 2017.

E. Usa, D. Stewart, R. Wilk, A. , R. Department et al., Office of the Chief Medical Officer, United Network for Organ Sharing, USA. KAS Turns Four: The State of Deceased Donor Kidney Allocation in the U.S. obm transplant, vol.3, pp.1-1, 2018.

R. A. Montgomery, B. E. Lonze, K. E. King, E. S. Kraus, L. M. Kucirka et al., Desensitization in HLA-Incompatible Kidney Recipients and Survival, New England Journal of Medicine, vol.365, issue.4, pp.318-326, 2011.

A. A. Vo, A. Sinha, M. Haas, J. Choi, J. Mirocha et al., Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization, Transplantation, vol.99, issue.7, pp.1423-1430, 2015.

D. S. Keith and G. M. Vranic, Approach to the Highly Sensitized Kidney Transplant Candidate, Clinical Journal of the American Society of Nephrology, vol.11, issue.4, pp.684-693, 2016.

S. U. Akgul, H. S. Ciftci, S. Temurhan, Y. Caliskan, A. Bayraktar et al., Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates, Transplantation Proceedings, vol.49, issue.3, pp.425-429, 2017.

P. Singh, E. J. Filippone, B. W. Colombe, A. P. Shah, T. Zhan et al., Sensitization trends after renal allograft failure: the role of DQ eplet mismatches in becoming highly sensitized, Clinical Transplantation, vol.30, issue.1, pp.71-80, 2015.

H. Lee, J. W. Min, J. Kim, I. Moon, K. Park et al., Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients, Medicine, vol.95, issue.11, p.e3094, 2016.

G. Opelz, B. Graver, M. R. Mickey, and P. I. Terasaki, LYMPHOCYTOXIC ANTIBODY RESPONSES TO TRANSFUSIONS IN POTENTIAL KIDNEY TRANSPLANT RECIPIENTS, Transplantation, vol.32, issue.3, pp.177-183, 1981.